Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary
Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints
Part 5. Global market for embolic agents by product
5.1 Beads & particles
5.1.1 Market size and forecast
5.2 Coils
5.2.1 Market size and forecast
5.3 Detachable balloons
5.3.1 Market size and forecast
5.4 Glue
5.4.1 Market size and forecast
5.5 Liquid embolics
5.5.1 Market size and forecast
5.6 Plugs
5.6.1 Market size and forecast
5.7 Precipitating agents
5.7.1 Market size and forecast
5.8 Sclerosants
5.8.1 Market size and forecast
5.9 Sponge
5.9.1 Market size and forecast
5.10 Others
5.10.1 Market size and forecast
Part 6. Global market for embolic agents by application
6.1 Oncology
6.1.1 Market size and forecast
6.2 Neurology
6.2.1 Market size and forecast
6.3 Urology
6.3.1 Market size and forecast
6.4 Cardiology
6.4.1 Market size and forecast
6.5 Peripheral vascular diseases
6.5.1 Market size and forecast
6.6 Others
6.6.1 Market size and forecast
Part 7. Global market for embolic agents by end user
7.1 Hospitals
7.1.1 Market size and forecast
7.2 Cardiac centers
7.2.1 Market size and forecast
7.3 Ambulatory surgical centers (ASCs)
7.3.1 Market size and forecast
7.4 Others
7.4.1 Market size and forecast
Part 8. Global market for embolic agents by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast
Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 Boston Scientific Corporation
9.3 Cook Group Incorporated
9.4 Johnson & Johnson
9.5 Kaneka Corporation
9.6 Medtronic plc
9.7 Merit Medical Systems, Inc.
9.8 Penumbra, Inc.
9.9 Stryker Corporation
9.10 Terumo Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY